DOLIVER ADVISORS, LP BCRX Holdings History
DOLIVER ADVISORS, LP's BioCryst Pharmaceuticals Inc Holding Summary
As of 2025-06-30, DOLIVER ADVISORS, LP held 274,328.00 shares of BioCryst Pharmaceuticals Inc(BCRX), totaling $2.46 Mil. This investment constitutes 0.67% of their stock portfolio, and DOLIVER ADVISORS, LP now holds 0.13% of the outstanding BioCryst Pharmaceuticals Inc(BCRX) stock.
The initial trade took place in 2021Q3. And since then DOLIVER ADVISORS, LP has made 2 purchases of BCRX, at an average price of $11.45, for a total of 300,000.00 shares. In addition, there have been 2 sales at an average price of $13.87 for 25,672.00 shares. Based on historical transaction data and BCRX's current price of $8.76, DOLIVER ADVISORS, LP's estimated gain on his BCRX holdings is $-674,916.24, reflecting a -19.65% gain to date.
DOLIVER ADVISORS, LP BCRX ($8.76) Holding Chart
DOLIVER ADVISORS, LP BCRX ($8.76) Quarterly Buys and Sells
| Period | Bought/Sold (Sh.) | % Change | Qtr. End Shares | Avrg. Price |
|---|---|---|---|---|
| Shares Bought | 0 | Average Price $-/Share | ||
| Shares Sold | 0 | Average Price $-/Share | ||
| Current Price $0.00 | Total Estimated Gain 0 % | |||
Top Ranked Articles
- 1
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
